-
1
-
-
46049090201
-
American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
-
Geerts WH, Bergqvist D, Pineo GF, et al; American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:381S-453S.
-
(2008)
Chest
, vol.133
-
-
Geerts, W.H.1
Bergqvist, D.2
Pineo, G.F.3
-
2
-
-
74349115633
-
-
Medicare Quality Improvement Community (MedQIC) Web site. Accessed June 1
-
Medicare Quality Improvement Community (MedQIC) Web site. http://www.medqic.org. Accessed June 1, 2009.
-
(2009)
-
-
-
3
-
-
74349083089
-
-
Surgical Care Improvement Project (SCIP). Accessed June 1
-
Surgical Care Improvement Project (SCIP). Colorado Foundation for Medical Care Web site. http://www.cfmc.org/hospital/hospital_ scip.htm. Accessed June 1, 2009.
-
(2009)
Colorado Foundation for Medical Care Web site
-
-
-
4
-
-
14744275842
-
Electronic alerts to prevent venous thromboembolism among hospitalized patients
-
Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005; 352:969-977.
-
(2005)
N Engl J Med
, vol.352
, pp. 969-977
-
-
Kucher, N.1
Koo, S.2
Quiroz, R.3
-
6
-
-
0034565939
-
Elastic compression stockings for prevention of deep vein thrombosis
-
Amaragiri SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 2000; (3):CD001484.
-
(2000)
Cochrane Database Syst Rev
, Issue.3
-
-
Amaragiri, S.V.1
Lees, T.A.2
-
7
-
-
0036632825
-
Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST Practice Management Work Group
-
Rogers FB, Cipolle MD, Velmahos G, et al. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST Practice Management Work Group. J Trauma 2002; 53:142-164.
-
(2002)
J Trauma
, vol.53
, pp. 142-164
-
-
Rogers, F.B.1
Cipolle, M.D.2
Velmahos, G.3
-
8
-
-
0037187892
-
Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer
-
Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002; 346:975-980.
-
(2002)
N Engl J Med
, vol.346
, pp. 975-980
-
-
Bergqvist, D.1
Agnelli, G.2
Cohen, A.T.3
-
9
-
-
0037054040
-
Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study
-
Heit JA, O'Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002; 162:1245-1248.
-
(2002)
Arch Intern Med
, vol.162
, pp. 1245-1248
-
-
Heit, J.A.1
O'Fallon, W.M.2
Petterson, T.M.3
-
10
-
-
34447641374
-
Venous thromboembolism in the outpatient setting
-
Spencer FA, Lessard D, Emery C, et al. Venous thromboembolism in the outpatient setting. Arch Intern Med 2007; 167:1471-1475.
-
(2007)
Arch Intern Med
, vol.167
, pp. 1471-1475
-
-
Spencer, F.A.1
Lessard, D.2
Emery, C.3
-
11
-
-
0034726370
-
Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis
-
Iorio A, Agnelli G. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med 2000; 160:2327-2332.
-
(2000)
Arch Intern Med
, vol.160
, pp. 2327-2332
-
-
Iorio, A.1
Agnelli, G.2
-
12
-
-
13244260755
-
Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis
-
Mismetti P, Laporte S, Zufferey P, et al. Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis. J Thromb Haemost 2004; 2:1058-1070.
-
(2004)
J Thromb Haemost
, vol.2
, pp. 1058-1070
-
-
Mismetti, P.1
Laporte, S.2
Zufferey, P.3
-
13
-
-
0037048227
-
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized doubleblind studies
-
Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized doubleblind studies. Arch Intern Med 2002; 162:1833-1840.
-
(2002)
Arch Intern Med
, vol.162
, pp. 1833-1840
-
-
Turpie, A.G.1
Bauer, K.A.2
Eriksson, B.I.3
Lassen, M.R.4
-
14
-
-
0035522304
-
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery
-
Steering Committee of the Pentasaccharide in Major Knee Surgery Study
-
Bauer KA, Eriksson BI, Lassen MR, Turpie AG; Steering Committee of the Pentasaccharide in Major Knee Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 2001; 345:1305-1310.
-
(2001)
N Engl J Med
, vol.345
, pp. 1305-1310
-
-
Bauer, K.A.1
Eriksson, B.I.2
Lassen, M.R.3
Turpie, A.G.4
-
15
-
-
33745909893
-
Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence)
-
Cardiovascular Disease Educational and Research Trust; Cyprus Cardiovascular Disease Educational and Research Trust; European Venous Forum; International Surgical Thrombosis Forum; International Union of Angiology; Union Internationale de Phlébologie
-
Cardiovascular Disease Educational and Research Trust; Cyprus Cardiovascular Disease Educational and Research Trust; European Venous Forum; International Surgical Thrombosis Forum; International Union of Angiology; Union Internationale de Phlébologie. Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol 2006; 25:101-161.
-
(2006)
Int Angiol
, vol.25
, pp. 101-161
-
-
-
16
-
-
74349090318
-
-
American Academy of Orthopaedic Surgeons clinical guideline on prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. Accessed June 5
-
American Academy of Orthopaedic Surgeons clinical guideline on prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. http://www.aaos.org/research/guidelines/PE_summary.pdf. Accessed June 5, 2009.
-
(2009)
-
-
-
17
-
-
0034655567
-
-
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial
-
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355:1295-1302.
-
(2000)
Lancet
, vol.355
, pp. 1295-1302
-
-
-
18
-
-
74349087714
-
-
Arixtra injection [package insert]. Research Triangle Park, NC: GlaxoSmithKline
-
Arixtra injection [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2008.
-
(2008)
-
-
-
19
-
-
0001290317
-
Enoxaparin pharmacokinetics and pharmacodynamics in renal impairment
-
Abstract
-
Sanderink GJ, Guimart C, Jariwala N, et al. Enoxaparin pharmacokinetics and pharmacodynamics in renal impairment. J Am Coll Cardiol 2001; 37(suppl A):229A. Abstract.
-
(2001)
J Am Coll Cardiol
, vol.37
, Issue.SUPPL A
-
-
Sanderink, G.J.1
Guimart, C.2
Jariwala, N.3
-
20
-
-
45949086068
-
American College of Chest Physicians. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) [published correction appears in Chest 2008; 134:473]
-
Hirsh J, Bauer KA, Donati MB, et al; American College of Chest Physicians. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) [published correction appears in Chest 2008; 134:473]. Chest 2008; 133:141S-159S.
-
(2008)
Chest
, vol.133
-
-
Hirsh, J.1
Bauer, K.A.2
Donati, M.B.3
-
21
-
-
0038630900
-
Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients
-
Frederiksen SG, Hedenbro JL, Norgren L. Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients. Br J Surg 2003; 90:547-548.
-
(2003)
Br J Surg
, vol.90
, pp. 547-548
-
-
Frederiksen, S.G.1
Hedenbro, J.L.2
Norgren, L.3
-
22
-
-
0036174636
-
A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery
-
Scholten DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 2002; 12:19-24.
-
(2002)
Obes Surg
, vol.12
, pp. 19-24
-
-
Scholten, D.J.1
Hoedema, R.M.2
Scholten, S.E.3
-
25
-
-
35449007749
-
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial
-
Eriksson BI, Dahl OE, Rosencher N, et al. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost 2007; 5:2178-2185.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 2178-2185
-
-
Eriksson, B.I.1
Dahl, O.E.2
Rosencher, N.3
-
26
-
-
57649123692
-
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery
-
RE-MOBILIZE Writing Committee, Ginsberg JS, Davidson BL, et al. Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty 2009; 24:1-9.
-
(2009)
J Arthroplasty
, vol.24
, pp. 1-9
-
-
Writing Committee, R.-M.1
Ginsberg, J.S.2
Davidson, B.L.3
-
27
-
-
34548575058
-
RE-NOVATE Study Group. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial [published correction appears in Lancet 2007; 370:2004]
-
Eriksson BI, Dahl OE, Rosencher N, et al; RE-NOVATE Study Group. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial [published correction appears in Lancet 2007; 370:2004]. Lancet 2007: 370:949-956.
-
(2007)
Lancet
, vol.370
, pp. 949-956
-
-
Eriksson, B.I.1
Dahl, O.E.2
Rosencher, N.3
-
28
-
-
0031760564
-
Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII
-
Hoffman M, Monroe DM 3rd, Roberts HR. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis 1998; 9(suppl 1):S61-S65.
-
(1998)
Blood Coagul Fibrinolysis
, vol.9
, Issue.SUPPL 1
-
-
Hoffman, M.1
Monroe D.M. 3rd2
Roberts, H.R.3
-
29
-
-
74349111717
-
-
Bristol-Myers Squibb and Pfizer provide update on apixaban clinical development program [press release]. New York, NY: August
-
Bristol-Myers Squibb and Pfizer provide update on apixaban clinical development program [press release]. New York, NY: August 27, 2008.
-
(2008)
, vol.27
-
-
-
30
-
-
65549169515
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
-
Turpie AG, Lassen MR, Davidson BL, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet 2009; 373:1673-1680.
-
(2009)
Lancet
, vol.373
, pp. 1673-1680
-
-
Turpie, A.G.1
Lassen, M.R.2
Davidson, B.L.3
|